Effects of Intranasal Oxytocin in Patients With Arginine-vasopressin Deficiency

NCT04789148 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Vasopressin Deficiency

Interventions

DRUG: Intranasal Oxytocin (IN-OXT)
DRUG: Intranasal Oxytocin (IN-OXT)
DRUG: Placebo
DRUG: Intranasal Oxytocin (IN-OXT)
DRUG: Placebo

Sponsor

Elizabeth Austen Lawson

Collaborators

[object Object]